Monday, October 27, 2025

Compass Pathways President Steps Down To An Advisory Role

Compass Pathways (Nasdaq: CMPS) announced this morning major changes to its executive team. One of its co-founders, President and Chief Business Officer Lars Wilde is stepping down to take a senior advisory role.

“We have built an amazing company at COMPASS and I am grateful to everyone who continues to support us,” Wilde said in a statement. “This is a natural time for me to transition to an advisory role and I am proud to be able to continue working with COMPASS.”

The move is effective as of January 1, 2022.

Wilde is said to have been integral to the company’s strategic and operational efforts, “including fundraising, business development, and the development of its Discovery Center.”

The firm also announced Matthew Owens as its General Counsel and Chief Legal Officer starting February 1, 2022, while Mike Falvey was announced as the incoming CFO earlier this month.

Compass Pathways last traded at US$23.73 on the Nasdaq.


Information for this briefing was found via Edgar and Compass Pathways. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Goliath Resources Drills 10.72 g/t Gold Over 7.83 Metres At Surebet

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Related News

Compass Pathways Closes Enrollment For Phase IIb Psilocybin Clinical Trial

Compass Pathways (NASDAQ: CMPS) this morning provided a brief update to the market on the...

Monday, June 28, 2021, 07:37:00 AM

Compass Pathways, Psilocybin Research Firm, Files For Nasdaq IPO

It appears that some authenticity and validation might be coming to the psychedelics space. Compass...

Saturday, August 29, 2020, 11:43:00 AM

Compass Pathways To Start Phase II Trial For Psilocybin PTSD Therapy

Compass Pathways (Nasdaq: CMPS) this morning announced that it will be launching the phase II...

Wednesday, November 3, 2021, 09:52:00 AM

Compass Pathways Granted Its Tenth Overall Patent Related To Psilocybin

Compass Pathways (NASDAQ: CMPS) this morning issued a brief release, indicating it has been granted...

Tuesday, November 23, 2021, 07:55:20 AM

Andrew Left’s Citron Research Places $100 Price Target On Compass Pathways

Andrew Left of Citron Research today released a research paper on Compass Pathways (NASDAQ: CMPS),...

Monday, October 5, 2020, 07:01:00 PM